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Abstract
Background: San Huang Shel Shin Tang (SHSST) is a traditional herbal decoction used as a hepato-protective
agent and is composed of Rheum officinale Baill, Scutellaria baicalnsis Geprgi and Coptis chinensis Franch (2:1:1
w/w). Beta-cyclodextrin (β-CD) modification may potentially increase the solubility and spectral properties
of SHSST.
Methods: In this research, the hepato-protective effects of unmodified SHSST, β-CD modified SHSST complex
(SHSSTc) and silymarin were evaluated in carbon tetrachloride (CCl4) induced acute hepatotoxicity in rats.
Results: SHHSTc (40 mg/kg/day) and silymarin (100 mg/kg/day) both decreased the CCl4-induced cirrhosis
pathway-related transforming growth factor beta (TGF-β) and apoptosis pathway-related caspase-8 protein
expressions, but SHSST (40 mg/kg/day) did not reduce TGF-β and caspase-8 significantly . Moreover, SHHSTc
(40 mg/kg/day) enhanced the activation of insulin-like growth factor 1 receptor (IGF1R) mediated survival
pathway than the silymarin (100 mg/kg/day) to protect the liver from damage induced by CCl4.
Conclusions: β-CD modification promotes hepato-protective effects of SHSST and reduces the
required-dosage of the SHSST.
Keywords: San Huang Shel Shin Tang (SHSST), Beta-cyclodextrin, Silymarin, CCl4, Liver protection
Background
Hepatic fibrosis is one of the most critical pathological
features of chronic liver disease. Liver fibrosis is associ-
ated with the inflammatory and reparative phase of hep-
atic fibrosis by activated hepatic stellate cells (HSC) and
can be characterized by an excessive deposition of extra-
cellular matrix (ECM) components in the liver paren-
chyma [1]. Liver fibrosis is known to be a serious
chronic disease and it is difficult to treat with an aggres-
sive treatment due to possible cirrhosis outcomes. This
makes it necessary to develop a new complex or cocktail
of more efficient drugs with sufficiently low dosages to
prevent side effects.
SHSST is a cocktail of traditional herbal decoction,
with reported bioactivities such as hypotension, antioxi-
dation, anti-inflammation and cardio-protective effects
[2]. Rheum was discovered to have a hepato-protective
effect and can be used to treat carbon tetrachloride
(CCl4)-induced liver injury in rats [3, 4]. Scutellaria and
Coptis were also reported to elicit similar liver protec-
tion against acute hepatotoxicity [5–7]. The similar liver
protection effects of Rheum officinale, Scutellaria
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baicalnsis and Coptis chinensis are due to the similarity
in the constituent bioactive compounds such as baica-
lein, which is a flavonoid [8–10].
In our previous study, the tumor necrosis factor ligand
superfamily member 6 (FAS) was activated in the course
of CCl4-induced liver failure, with down stream apop-
totic protein caspase-8 on Fas-associated protein with
death domain (FADD) released to cytosol, causing cleav-
age of caspase 3 and progression of cellular apoptosis
[11, 12]. CCl4 induced liver failure occurs through an
oxidation process when CCl4 is transported through the
vascular system to the liver and by catalysis by mixed
function oxidase (MFO) such as P450, changes into me-
thane chloride or radicals. These radicals cause protein
metabolic obstruction and inflammation in the liver,
producing CCl4 induced acute liver injury [13, 14]. Sily-
marin can provide an anti-oxidation function to block
the CCl4 catalyzing process and protect the liver from
CCl4 induced acute liver injury but not through the
P450 inhibition [15]. Many flavonoid compounds play
the same role with their anti-oxidative function. Baica-
lein in SHSST can also enhance cell survival ability
through PI3K-Akt pathway activation. The active Akt
can keep the Bcl-2-associated death promoter (Bad) pro-
tein in phosphorylated type and prevent cell apoptosis
[16]. Here, the liver protection function of SHSST was
tested and compared with silymarin.
In our previous research, beta- cyclodextrin (β-CD) in-
creased the solubility and spectral properties of guest
molecules, especially the hydrophobic drugs, without
changing their intrinsic property to permeate the cell
membranes [17–19]. Thus, β-CD complex synthesis with
the indicated compound or herbal decoction can en-
hance the solubility, stability and bioavailability of drugs
[20, 21]. This research evaluated the liver protection ef-
fects of the β-CD modified SHSST complex (SHSSTc),
SHSST and silymarin in CCl4 induced acute hepato-
toxicity in rats.
Methods
Preparation of SHSST and SHSST-β-CD complex
The SHSST was purchased from PaiAn pharmacy
(Taichung, Taiwan). The SHSST-β-CD complex was pre-
pared by coprecipitation. β-CD (70.0 g) was dissolved in
distilled water (85 ml) at 70 °C in a water bath for 1 h.
SHSST (10.0 g) in ethanol (15 mL) was slowly added to
the β-CD solution with continuous agitation and stirred
continuously for 6 h. Following that, 40 mL of ethanol
was added drop wise to regulate the solubility of the
hydrophobic solute in β-CD solution. The solution was
then refrigerated overnight at 4 °C. The precipitated
SHSSTc (SHSST-β-CD complex, SHSST: β-CD = 1: 9 in
weight) was recovered by filtration and washed with
ethanol to remove unencapsulated SHSST. This residue
was dried in a vacuum oven at −20 °C for 48 h. The final
powder was stored at 4 °C until use.
Animal model
The animal experimental protocol was approved by the
Institutional Animal Care and Use Committee (IACUC)
of China Medical University (No.100-3-B, date 2010-9-
1). There were 30 SD rats (300 g in body weight, aged
10 weeks) purchased from BioLASCO Taiwan Co., Ltd
and were divided into 5 groups (n = 6 each). The groups
were designated as control, CCl4 (Sgma-Aldrich, Taipei,
Taiwan) intraperitoneal injection treatment, CCl4 intra-
peritoneal injection combined with SHSSTc (40 mg/kg/
day) oral treatment, CCl4 intraperitoneal injection com-
bined with SHSST oral treatment (40 mg/kg/day), CCl4
intraperitoneal injection combined with silymarin
(Sigma-Aldrich, Taipei, Taiwan) oral treatment. CCl4 in-
traperitoneal injection (100 mg/kg/day) treatment was
performed on the 7th day following 6 days of pretreat-
ment with the test materials. After 24 h CCl4 intraperi-
toneal injection, all the rats were killed by decapitation
and samples were collected immediately.
Blood biochemical analysis
Blood was collected from rat in each group during the
while decapitation and measured using the blood routine
examination protocol at China Medical University Hos-
pital. The following parameters were analyzed: TC (total
cholesterol), cholesterol, AST (aspartate transaminase),
ALT (alanine transaminase), BUN (blood urea nitrogen),
CK (creatine kinase).
Hemotoxyline and eosin staining
Livers from rats in each group were soaked in 10 % forma-
lin, dehydrated through graded alcohols and embedded in
Table 1 Blood Biochemical analysis of the experimental rats
Control None SHSSTc SHSST Silymarin
CCl4 - + + + +
AST 28.0 ± 2.5 42.9 ± 9.7*** 25.9 ± 5.1## 38.6 ± 11.6 35.1 ± 3.9
ALT 27 ± 14 195 ± 20*** 93 ± 15### 116 ± 19## 124 ± 25##
TC 50 ± 15 57 ± 14 50 ± 15 56 ± 17 50 ± 18
TG 45 ± 20 54 ± 19 46 ± 43 47 ± 13 46 ± 13
CK 483 ± 56 1399 ± 147*** 998 ± 63# 1137 ± 85 1024 ± 72#
BUN 29 ± 7 35 ± 7 31 ± 6 33 ± 7 32 ± 7
All plasma samples (n = 6) were prepared from control group, CCl4-induced
acute hepatotoxicity group, CCl4-induced acute hepatotoxicity combined
SHSST treatment group, CCl4-induced acute hepatotoxicity combined SHSSTc
treatment group, CCl4-induced acute hepatotoxicity combined silymarin
treatment group were calculated and shown. TC total cholesterol (mg/dL),
TG triacylglycerol (mg/dL), AST aspartate transaminase (U/L), ALT alanine
transaminase (U/L), BUN blood urea nitrogen (mg/dL), CK creatine kinase (U/L).
( *** = P <0.001 compared with control group, # = P <0.05 compared with
CCl4-IP group, ## = P <0.01 compared with CCl4-IP group, ### = P <0.001
compared with CCl4-IP group)
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paraffin wax. Following that, 2 μm thick paraffin sec-
tions were cut from these paraffin-embedded tissue
blocks. The tissue sections were deparaffinized by
immersion in xylene and rehydrated. Sections were
stained with hematoxylin and eosin (H&E), immersed
in graded alcohols followed by xylene and mounted
in mounting medium kit (Surgipath, Leica Biosystems,
Instrument Co., Richmond, USA). Photomicrographs
were obtained using Zeiss Axiophot microscopes
(Taiwan Instrument Co., Taipei, Taiwan).
Masson’s trichrome staining
Rat livers from each group were soaked in 10 % forma-
lin, dehydrated through graded alcohols and embedded
in paraffin wax. Following that, 2 μm thick paraffin
sections were cut from these paraffin-embedded tissue
Fig. 1 Hematoxylin and eosin stain (H&E) and Massion’s trichrome stain (MT) of liver slides. H&E stain show the CCl4 induce damaged group
rat livers caused the lipid accumulation around the capillary and indicated by black arrows. SHSST and silymarin treatments provided a slight
reduction in lipid accumulation. But SHSSTc treatment protected the liver and prevented the cell death. MT stain shows a serious liver fibrosis
in CCl4-damaged rat liver group and are indicated by white arrows. After the silymarin, SHSST and SHSSTc treatments all can provide a great
anti-fibrosis effect in CCl4 induced damaged rat livers. (The nuclei of the cells are stained with blue color, and others are stained by pink color
by H&E staining assay. The fibrosis cells are indicated by blue color and normal cells are indicated by pink color in MT staining assay)
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blocks. The tissue sections were deparaffinized by
immersion in xylene and rehydrated. Samples were then
stained with Masson’s trichrome (MT) using HT15
Sigma Trichrome stain (Masson) kit (HT1079, Sigma-
Aldrich, Taipei, Taiwan) and the procedure was accord-
ing to the protocol of the kit. MT satin was used to
investigate liver histological and fibrotic changes and
photomicrographs were obtained using Zeiss Axiophot
microscopes (Taiwan Instrument Co., Taipei, Taiwan).
Tissue protein extraction
Liver tissue extracts from 6 rats in each group were
obtained by homogenizing in a lysis buffer (0.05 M
Tris–HCl, pH 7.4, 0.15 M NaCl, 0.25 % deoxycholic acid,
1 % NP-40, 1 mM EDTA) at a ratio of 100 mg tissue/
1 ml buffer. The homogenates were placed on ice and
then centrifuged at 13,000 rpm for 40 min. The superna-
tants were collected and stored at −80 °C for further
experiments.
Western blot assay
Liver tissue extract protein concentrations were deter-
mined using the Lowry protein assay. Protein samples
were separated in a 12 % SDS polyacrylamide gel
electrophoresis (SDS-PAGE) with a constant voltage of
75 V for 120 min. Proteins were then transferred to
Hybond-C membranes (GE healthcare UK limited.,
Buckinghamshire, UK) using 50 volt for 3 h. PVDF
membranes were incubated in 3 % bovine serum albu-
min (BSA) in Tris-buffered solution (TBS). Primary anti-
bodies (Santa Cruz Biotechnology, CA, USA) were
added into the membranes to recognize the respective
proteins. After washing 3 times, horseradish peroxidase-
labeled antibodies were then used. Last, after 3 times
washed and pictures were taken with Fujifilm LAS-3000
(GE healthcare UK limited, Buckinghamshire, UK).
Statistical analysis
The results shown are the means ± SD of three inde-
pendent experiments. Statistical analysis was performed
using one-way analysis of variants. The Student’s t-test
was used for paired samples.
Results
After 24 h CCl4 intraperitoneal injection treatment, the
parameters of TG and TC did not show any significant
change. AST and ALT were significantly expressed after
CCl4-IP treatment within 24 (Table 1). However, 7 days
Fig. 2 The TGF-β regulated fibrosis pathway protein expressions analysis. The protein sample of each group was analyzed by western blotting
assay. a TGF-β/p-Smad/CTGF protein expressions increased in CCl4-induced acute hepato-toxicity group and reduced in SHSSTc treatment group.
b The protein expression folds of TGF-β. c The protein expression folds of p-Smad. d The protein expression folds of CTGF. (* = P <0.05, ** = P
<0.01, *** = P <0.001, compared with control group.)
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pretreatments of SHSSTc and silymarin reduced the
cholesterol after CCl4 intraperitoneal injection. ALT
expression was especially reduced in SHSST, SHSSTc
and silymarin treatment groups while AST expression
was reduced only in the SHSSTc treatment group.
Further, H&E staining showed abnormal lipid accumu-
lation within the hepatocytes around the small vascular
of the liver 24 h after CCl4 treatment and these abnor-
mal morphology imply the presence of fat cells with vac-
uolated cytoplasm which is an indication of hepatic
steatosis. The SHSSTc and silymarin efficiently protected
the hepatocytes and decreased the abnormality around the
small vascular (Fig. 1). MT staining confirmed the fibrosis
area through the collagen accumulation in CCl4 induced
damaged liver and showed similar results in the SHSSTc
and silymarin treated rat livers. SHSSTc and silymarin
treatment inhibited the fibrosis and reduced the collagen
accumulation in CCl4 induced damaged rat livers.
TGF-β pathway activation is necessary for fibroblast
collagen secretion in the fibrosis process. CCl4 intraperi-
toneal injection treated groups rats showed highly
expressed TGF-β pathway proteins, such as p-Samd and
CTGF (Fig. 2a). The TGF-β pathway protein expression
showed a decrease in the SHSSTc and silymarin treated
groups similar to the control group. The unmodified
SHSST treated group did not show a significant re-
duction in TGF-β pathway protein expression. After
further calculation, the SHSSTc treatment decreased
TGF-β and p-Smad more efficiently than other treat-
ments (Fig. 2b, c) however, silymarin also provided
efficient reduction of CTGF in CCl4 induced liver
fibrosis (Fig. 2d).
FAS ligand and FAS complex are known to lead to the
formation of death inducing signal complex starting with
recruitment of the FAS associated death domain (FADD)
adaptor protein. FADD recruits and aggregates the pro-
form of caspase-8, leading to caspase-8 activation and
triggering the progression of apoptosis. The liver protein
analysis shows the FAS/ FADD/caspase-8 pathway acti-
vation in CCl4 treatment group within 24 h (Fig. 3a).
Silymarin and SHSST treatment did not reduce FAS and
FADD proteins by any significant level (Fig. 3b, c). How-
ever, downstream caspase-8 activation was indeed
blocked by SHSSTc and silymarin treatments (Fig. 3d)
The most important cell survival signaling pathway is
through the activation of PI3K/Akt. In SHSSTc treatment,
the p-PI3K and p-Akt were activated highly and main-
tained downstream Bad-phosphorylated (Fig. 4a). Finally,
Fig. 3 The FAS regulated apoptosis pathway protein expressions analysis. The protein sample of each group was analysis by western blotting
assay. a FAS/FADD/Caspase 8 protein expressions increased in CCl4-induced acute hepatotoxicity group and decreased in SHSSTc treatment
group. b The protein expression folds of FAS. c The protein expression folds of FADD. d The protein expression folds of Caspase 8. (* = P <0.05,
** = P <0.01, *** = P <0.001, compared with control group.)
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SHSSTc blocked caspase-3 cleavage stronger than SHSST
and silymarin treatment. Both the SHSST and SHSSTc
were effective than the silymarin in enhancing IGF recep-
tor phosphorylation (Fig. 4b), and its downstream p-PI3K/
p-Akt/p-Bad (Fig. 4c, d, e). The Caspase-3 expression was
also partly reduced by SHSST and silymarin treatments,
but was totally blocked by SHSSTc treatment (Fig. 4f).
Discussion
CCl4 can be changed into CHCl3 through oxidation in the
liver [22]. However, the products after CCl4 oxidation also
include free radicals, such as trichloromethyl free radical
(CCl3•) and trichloromethylperoxyl free radical (CCl3OO•),
these free radical compounds will react with the lipopro-
tein in hepatocytes causing cholesterol accumulation be-
cause of the problems in lipid metabolism [23]. Silymarin
can provide an anti-oxidant function and reduce the
amount of free radicals in the liver, providing liver protec-
tion [24]. The flavonoids rich SHSST might also present a
similar function, but the result shown the liver protection
effect of SHSST was still very week (Table 1, Fig. 1).
SHSSTc treatment acts better than SHSST even silymarin
owing to the modulations in its bioavailability for being
modified with the β-CD complex.
Silymarin is reported to provide protection against
liver cirrhosis and it reduces the levels of hepatic fibrosis
markers including serum TGF-β1, especially in the CCl4
induced liver injury model [25]. TGF-β1/p-Smad signal-
ing expression can enhance collagen synthesis in fibro-
blasts [26]. The MT staining assay showed collagen
accumulation in the CCl4 induced liver fibrosis group
and TGF-β1/p-Smad signaling over expression within
24 h (Figs. 1, 2). In 1 week pretreatment with silymarin
and SHSSTc, TGF-β1/p-Smad signaling and collagen ac-
cumulation were blocked (Fig. 1, 3). The experimental
data suggests that SHSSTc and silymarin have similar
anti- cirrhosis effects.
SHSSTc treatment efficiently protects the hepatocytes
in CCl4 induced liver injury. The possible protection
mechanism is through FAS/FADD/caspase-8 apoptosis
pathway inhibition and IGF1R/PI3K/Akt survival path-
way activation [27, 28] (Fig. 4). Here, silymarin could
only inhibit apoptosis through caspase-8 suppression but
not through IGF1R pathway activation. This may be
the difference between SHSSTc and silymarin in liver
protection which makes SHSSTc protect the liver bet-
ter than silymarin in this CCl4 induced liver injury
animal model.
Fig. 4 The PI3K regulated survival pathway protein expressions analysis. The protein sample of each group was analysis by western blotting assay.
a p-IGF1R/p-PI3K/p-Akt/p-Bad protein expressions decreased in CCl4-induced acute hepatotoxicity group and increased in SHSSTc treatment
group. Apoptotic protein Caspase 3 was increased in CCl4-induced acute hepatotoxicity group and decreased in SHSSTc treatment group. b The
protein expression folds of p-IGF1R. c The protein expression folds of p-PI3K. d The protein expression folds of p-Akt. e The protein expression
folds of p-Bad. f The protein expression folds of Caspase 3. (* = P <0.05, ** = P <0.01, *** = P <0.001, compared with control group, # = P <0.05,
## = P <0.01, ### = P <0.001, compared with CCl4 treatment group.)
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The bioactive compounds of SHSST represent anthra-
quinones, such as emodin, aloe-emodin, chrysophanol,
and flavones such as baicalin, baicalein, wogonoside,
wogonin, and alkaloids such as berberine, palmatine,
coptisine [29]. The components from silymarin are
flavonols such as silybin, isosilybin, silydianin, and sily-
christin [30]. The chemical structures of all of these
components are shown in Fig. 5. The structures of
bioactive compounds from SHSST belong to the flavone
and flavonol groups. Although the bioavailability of
flavonol is greater than for flavones, the large functional
groups in silymarin derivatives might decrease the ori-
ginal benefits of flavonol. The small molecular weight of
the bioactive compounds from SHSST might enhance
Fig. 5 The list of bioactive compounds from SHSST and silymarin
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the diffusion ability. Thus, the β-CD modification can
increase the water solubility of hydrophobic flavone
compounds and improve the hepatoprotective effects.
The SHSSTc was formed by SHSST and β-CD at the
ratio of 1:9 by weight and the water solubility, stability
and bioavailability were promoted better than by SHSST.
Actually, both the anti-cirrhosis and liver protection
effects of SHSSTc treatment were better than the other
groups in the CCl4 induced acute liver injury animal
model.
Conclusions
SHSST modification with β-CD complex to SHSSTc en-
hances the liver protection effects of SHSST. SHSSTc
shows similar inhibitory effects with silymarin in the
FAS/FADD/caspase-8 apoptosis pathway and TGF-β
fibrosis pathway. However, SHSSTc augmented the IGF1R/
PI3K/Akt survival pathway more than silymarin and
displayed stronger protection against CCl4 induced liver
injury.
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